Merck EVP gets stock option and RSU grants
Merck & Co., Inc. executive Richard R. DeLuca, EVP & President of Merck Animal Health, reported compensation-related equity grants rather than open-market trades.
Rhea-AI Filing Summary
Merck & Co., Inc. executive Richard R. DeLuca, EVP & President of Merck Animal Health, reported compensation-related equity grants rather than open-market trades. He received 34,924 stock options with an exercise price of $113.15 per share, which vest in three equal installments on 5/5/2027, 5/5/2028, and 5/5/2029, and expire on 5/4/2036.
DeLuca also received 11,931 restricted stock units, each representing one share of Merck common stock, vesting and settling in three equal installments on 5/5/2027, 5/5/2028, and 5/5/2029. Following these grants, he holds 161,537.0700 common shares directly and 1,320.9907 shares indirectly through a 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 46,855 shares
Grant/Award
4 txns
Insider
DeLuca Richard R.
Role
EVP&Pres, Merck Animal Heallth
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 11,931 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 34,924 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock - 401(k) Plan | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 11,931 contracts (Direct);
Stock Option (Right to Buy) — 34,924 contracts (Direct);
Common Stock — 161,537.07 shares (Direct);
Common Stock - 401(k) Plan — 1,320.9907 shares (Indirect, By 401(k))
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- F2. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
- F3. The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
Key Figures
Stock options granted: 34,924 shares
Option exercise price: $113.15 per share
RSUs granted: 11,931 units
+5 more
8 metrics
Stock options granted
34,924 shares
Stock Option (Right to Buy) granted on 5/5/2026
Option exercise price
$113.15 per share
Conversion or exercise price of stock options
RSUs granted
11,931 units
Restricted Stock Unit grant on 5/5/2026
Direct common stock holding
161,537.0700 shares
Total common shares following transaction, direct ownership
401(k) common stock holding
1,320.9907 shares
Common Stock - 401(k) Plan, indirect ownership
Option vesting dates
5/5/2027, 5/5/2028, 5/5/2029
Equal installments when options vest and become exercisable
Option expiration date
5/4/2036
Expiration of stock options if unexercised
RSU vesting schedule
5/5/2027–5/5/2029
RSUs vest and distribute in three equal installments
Key Terms
Restricted Stock Unit, Stock Option (Right to Buy, 401(k) Plan, vests and becomes exercisable
4 terms
Restricted Stock Unit financial
"Each restricted stock unit represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (Right to Buy financial
"Stock Option (Right to Buy) with an exercise price of 113.1500"
401(k) Plan financial
"Common Stock - 401(k) Plan held indirectly by 401(k)"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
vests and becomes exercisable financial
"The option vests and becomes exercisable in equal installments on 5/5/2027"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Merck (MRK) executive Richard DeLuca report in this Form 4?
Richard DeLuca reported equity compensation grants, not open-market trades. He received stock options and restricted stock units that vest over time, along with updated holdings in Merck common stock held directly and through a 401(k) plan.
How many stock options did Richard DeLuca receive from Merck (MRK)?
Richard DeLuca received 34,924 stock options. These options have an exercise price of $113.15 per share and vest in three equal installments on 5/5/2027, 5/5/2028, and 5/5/2029, with an expiration date of 5/4/2036.
What restricted stock unit (RSU) grant did Merck (MRK) report for Richard DeLuca?
Merck granted Richard DeLuca 11,931 restricted stock units. Each RSU represents a contingent right to one Merck common share and vests in three equal installments on 5/5/2027, 5/5/2028, and 5/5/2029, when shares are distributed.
When do Richard DeLuca’s new Merck (MRK) equity awards vest?
Both the stock options and restricted stock units vest over three years. Vesting occurs in equal installments on 5/5/2027, 5/5/2028, and 5/5/2029, aligning the executive’s compensation with longer-term company performance.
Do Richard DeLuca’s reported Merck (MRK) transactions involve stock sales?
The reported transactions involve grants of stock options and restricted stock units, not stock sales. The Form 4 shows acquisitions of derivative awards as part of compensation, with no open-market purchases or disposals indicated in the provided data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
